BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28929171)

  • 1. [Impact of European e-commerce liberalisation on pharmaceutical crime : The ALPhA research project].
    Sinn A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1245-1254. PubMed ID: 28929171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Operation Pangea - standing together in combat against international pharmaceutical crime].
    Smolka K; Gronwald K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1233-1239. PubMed ID: 28929174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime].
    Wittstock M; Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1228-1232. PubMed ID: 28980025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines].
    Wanko R; Unkelbach U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1221-1227. PubMed ID: 28921172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Task force for falsified medicines].
    Weber G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1240-1244. PubMed ID: 28905078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Falsified medicines in parallel trade].
    Muckenfuß H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1208-1213. PubMed ID: 28905079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [securPharm e. V. - a protective shield against falsified medicines].
    Bergen M; Hoferichter R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1255-1260. PubMed ID: 28929207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current cases of falsified medicinal products within the competence of the Federal Institute for Drugs and Medical Devices (BfArM) : Case studies and extent].
    Wittstock M; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1196-1202. PubMed ID: 28980029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Falsified pharmaceutical products : Legislative measures in the European Union and in Germany].
    Sträter B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1188-1195. PubMed ID: 28929177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Internet pharmacies and counterfeit drugs].
    Schweim JK; Schweim HG
    Med Klin (Munich); 2009 Feb; 104(2):163-9. PubMed ID: 19242667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present Status of Displaying Pharmaceutical Products for Sale on Flea Market Applications for Smartphones and the Responses to Illicit Selling by Service Providers].
    Kishimoto K; Takeuchi T; Fukushima N
    Yakugaku Zasshi; 2017 Dec; 137(12):1533-1541. PubMed ID: 28883213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
    Hurtado RL; Lasmar MC
    Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
    Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
    Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recovery of online drug markets following law enforcement and other disruptions.
    Van Buskirk J; Bruno R; Dobbins T; Breen C; Burns L; Naicker S; Roxburgh A
    Drug Alcohol Depend; 2017 Apr; 173():159-162. PubMed ID: 28259089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.
    Mackey TK; Liang BA
    Global Health; 2013 Oct; 9():45. PubMed ID: 24131576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Counterfeit Medicines in Internet and the Fakeshare European Project: Experiences and Activities in Spain].
    Catalán-Matamoros D; González-Ochando N; Pecharroman-Arribas H; Fernández-Muelas A; Bentolila-Benchimol SS; IbarraLorente M
    Rev Esp Salud Publica; 2016 Aug; 90():e1-e14. PubMed ID: 27529446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Herceptin® case : A case of falsification of medicinal products to a greater extent].
    Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1203-1207. PubMed ID: 28936679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Campaign against counterfeit drugs].
    Warnet S
    Rev Infirm; 2013; (193):8. PubMed ID: 24245394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.